Neonatal Staphylococcus Aureus Sepsis: a 20-year Western Australian experience.
Shadbolt R, We MLS, Kohan R, Porter M, Athalye-Jape G, Nathan E, Shrestha D, Strunk T.
J Perinatol. 2022 Nov;42(11):1440-1445. doi: 10.1038/s41372-022-01440-3. Epub 2022 Jun 25.
PMID:35752689
Beyond sepsis: Staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity.
Dong Y, Speer CP, Glaser K.
Virulence. 2018 Jan 1;9(1):621-633. doi: 10.1080/21505594.2017.1419117.
PMID:29405832
Epidemiology of Staphylococcus haemolyticus nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage.
Martins Simões P, van der Mee-Marquet N, Youenou B, Ranc AG, Dupieux-Chabert C, Menard G, Dupin C, Butin M, Vandenesch F, Laurent F, Berger-Carbonne A, Kolenda C, Tristan A; S. haemolyticus neonatal infections Study Group.
Euro Surveill. 2025 Mar;30(11):2400309. doi: 10.2807/1560-7917.ES.2025.30.11.2400309.
PMID:40116031
Look Who's Talking: Host and Pathogen Drivers of Staphylococcus epidermidis Virulence in Neonatal Sepsis.
Joubert IA, Otto M, Strunk T, Currie AJ.
Int J Mol Sci. 2022 Jan 13;23(2):860. doi: 10.3390/ijms23020860.
PMID:35055041
Neonatal Staphylococcus aureus acquisition at a tertiary intensive care unit.
The role of Staphylococcus epidermidis in neonatal sepsis: guarding angel or pathogenic devil?
Dong Y, Speer CP.
Int J Med Microbiol. 2014 Jul;304(5-6):513-20. doi: 10.1016/j.ijmm.2014.04.013. Epub 2014 May 6.
PMID:24881963
Genomic Analysis of Multiresistant Staphylococcus capitis Associated with Neonatal Sepsis.
Carter GP, Ussher JE, Da Silva AG, Baines SL, Heffernan H, Riley TV, Broadbent R, van der Linden A, Lee J, Monk IR, Stinear TP, Howden BP, Williamson DA.